Fig. 7

YSV inhibited OSCC progression in vivo. (a) The diagram showing the establishment of Xenograft study models via injection of SCC-15 and CAL-27 cells; (b) Representative images of tumor samples; (c) Tumor volume (left) and tumor weight (right) of the mice injection of SCC-15 cells treated with 50 mg/kg YSV compared with the control group; (d) Tumor volume (left) and tumor weight (right) of the mice injection of CAL-27 cells treated with 50 mg/kg YSV compared with the control group; (e) HE staining images of tumor of the mice treated with 0 mg/kg and 50 mg/kg YSV. * P < 0.05, ** P < 0.01, *** P < 0.001, n = 3. Asterisks represent the differences between mice treated with 50 mg/kg YSV and 0 mg/kg YSV